New peptides show potency in blocking HIV entry into cellsNovember 14th, 2007 - 2:01 am ICT by admin
“In contrast, our D-peptides resist degradation, so they have the potential to be administered by mouth and last longer in the bloodstream. Since these inhibitors have a unique inhibitory mechanism, they should work well in combination with existing HIV inhibitors,” he added.
Writing about their work in the online edition of the Proceedings of the National Academy of Science, the researchers revealed that they were particularly interested in developing drugs to bind to an essential “pocket” structure found in all HIV strains.
Previous studies have already identified this essential structure as a promising drug target, using protein structures determined at the National Synchrotron Light Source (NSLS) at the U.S. Department of Energy’s Brookhaven National Laboratory. However, several earlier attempts to target this pocket failed to produce potent and non-toxic pocket-specific entry inhibitors.
In the current study, the researchers used a high-throughput technique to screen a “library” containing hundreds of millions of peptides to identify the rare peptides, which would bind to the pocket structure and inhibit HIV entry.
Thereafter, the researchers analysed the structure of the most promising candidate peptides, using x-ray crystallography at the NSLS. They looked into how an extremely bright beam of x-rays, available only at synchrotron sources, bounces off and is refracted by the sample to determine the positions of individual atoms.
“These structures reveal details of how the peptides bind and guide the development of future inhibitors,” said paper co-author Annie Heroux, a biologist and crystallography specialist at Brookhaven Lab.
This structure-assisted design led to the discovery of D-peptides with up to a 40,000-fold improved antiviral potency over previously reported D-peptides. The structures also suggest ways to engineer the peptides to reduce the chance of drug resistance. (ANI)
- Promising new HIV drug keeps virus out of cells - Aug 19, 2010
- Disrupting key structure in TB bacterium could aid in new drug design - May 12, 2010
- Insight into structure of HIV protein may help design drugs - Jun 10, 2010
- How HIV resists AIDS preventing AZT drug - Sep 20, 2010
- Scientists unravel herpes virus protein structure - Jul 27, 2010
- Scientists discover key difference in 'kiss of death' sequence of TB bacteria - Oct 18, 2010
- New technique shows molecular-sized objects with greater clarity - Jul 04, 2011
- Irreversible inhibition of a protease central to hepatitis C infection: Study - Nov 29, 2010
- New substance to make passports fraud-proof - May 19, 2011
- Pump that bacteria use to resist drugs described - Feb 27, 2011
- Scientists discover pumps that allow bacteria to resist drugs - Sep 24, 2010
- X-ray technique peers beneath surfaces of artefacts - Mar 26, 2011
- How snakes lost their legs - Feb 08, 2011
- Breakthrough may lead to new HIV drugs - Feb 01, 2010
- Boffins unravel secret of ancient Mayan dye's longevity - Jul 31, 2010
Tags: bind, bright beam, brookhaven lab, brookhaven national laboratory, entry inhibitors, hiv entry, hiv strains, national academy of science, national synchrotron light, national synchrotron light source, nsls, peptides, proceedings of the national academy of science, promising candidate, promising drug target, refracted, said paper, synchrotron light source, synchrotron sources, x ray crystallography